Introducing Sciadonics, Inc.
Dr. Alvin Berger, MS, Ph. D, Prof., CEO Sciadonics, Inc.
Inflammation is a contributing cause of most diseases and conditions facing modern societies. Current nutritional- and pharmaceutical solutions are helpful, but inadequate, with limited efficacy and/or side effects. The market opportunity for combating inflammation will be $110 billion in 2020.
Sciadonic acid (SCI) is a unique, anti-inflammatory, eco-friendly, fatty acid derived from conifer species of plants, consumed by indigenous populations and in Traditional Chinese Medicine. It was removed from Western diets during industrialization. Dr. Berger has spent the last 30 years studying SCI. Over the course of 22 studies in various rodent- and animal cell models of oral- and topical inflammation, SCI decreased inflammation more than fish oil when compared, with a novel mechanism of action.
Dr. Berger co-founded Sciadonics, Inc. to commercialize SCI and other special fatty acids, with the goal of reducing our rampant chronic inflammation. As SCI can be used alone or in combination with- other nutritional oils (such as fish oil), anti-oxidants, and drugs, to combat chronic- and diverse forms of inflammation and associated symptoms (pain, discomfort, etc.), the market opportunity is enormous. Moreover, SCI can be added to food vehicles requiring a longer shelf life, a particular challenge for fish oils. Dr. Berger and colleagues have painstakingly identified seeds and other sources of SCI and related fatty acids that are economical, abundant, with a history of safe use, and protected by our intellectual property.
Inflammation is a contributing cause of most diseases and conditions facing modern societies. Current nutritional- and pharmaceutical solutions are helpful, but inadequate, with limited efficacy and/or side effects. The market opportunity for combating inflammation will be $110 billion in 2020.
Sciadonic acid (SCI) is a unique, anti-inflammatory, eco-friendly, fatty acid derived from conifer species of plants, consumed by indigenous populations and in Traditional Chinese Medicine. It was removed from Western diets during industrialization. Dr. Berger has spent the last 30 years studying SCI. Over the course of 22 studies in various rodent- and animal cell models of oral- and topical inflammation, SCI decreased inflammation more than fish oil when compared, with a novel mechanism of action.
Dr. Berger co-founded Sciadonics, Inc. to commercialize SCI and other special fatty acids, with the goal of reducing our rampant chronic inflammation. As SCI can be used alone or in combination with- other nutritional oils (such as fish oil), anti-oxidants, and drugs, to combat chronic- and diverse forms of inflammation and associated symptoms (pain, discomfort, etc.), the market opportunity is enormous. Moreover, SCI can be added to food vehicles requiring a longer shelf life, a particular challenge for fish oils. Dr. Berger and colleagues have painstakingly identified seeds and other sources of SCI and related fatty acids that are economical, abundant, with a history of safe use, and protected by our intellectual property.
Dr. Alvin Berger Speaks about Sciadonics
|
|
|
LEARN MORE
Watch this presentation for a look at Sciadonics, Inc.
|
|